These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 17852036)
1. DNA damage response and development of targeted cancer treatments. Gasser S Ann Med; 2007; 39(6):457-64. PubMed ID: 17852036 [TBL] [Abstract][Full Text] [Related]
2. The DNA damage response, immunity and cancer. Gasser S; Raulet D Semin Cancer Biol; 2006 Oct; 16(5):344-7. PubMed ID: 16914325 [TBL] [Abstract][Full Text] [Related]
3. The DNA damage response arouses the immune system. Gasser S; Raulet DH Cancer Res; 2006 Apr; 66(8):3959-62. PubMed ID: 16618710 [TBL] [Abstract][Full Text] [Related]
6. Induction of NKG2D ligands and subsequent enhancement of NK cell-mediated lysis of cancer cells by arsenic trioxide. Kim JY; Bae JH; Lee SH; Lee EY; Chung BS; Kim SH; Kang CD J Immunother; 2008 Jun; 31(5):475-86. PubMed ID: 18463537 [TBL] [Abstract][Full Text] [Related]
14. Ribosomal protein S27-like, a p53-inducible modulator of cell fate in response to genotoxic stress. Li J; Tan J; Zhuang L; Banerjee B; Yang X; Chau JF; Lee PL; Hande MP; Li B; Yu Q Cancer Res; 2007 Dec; 67(23):11317-26. PubMed ID: 18056458 [TBL] [Abstract][Full Text] [Related]
15. The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells. El-Sherbiny YM; Meade JL; Holmes TD; McGonagle D; Mackie SL; Morgan AW; Cook G; Feyler S; Richards SJ; Davies FE; Morgan GJ; Cook GP Cancer Res; 2007 Sep; 67(18):8444-9. PubMed ID: 17875681 [TBL] [Abstract][Full Text] [Related]
16. Decreased risk of colorectal cancer with the high natural killer cell activity NKG2D genotype in Japanese. Furue H; Matsuo K; Kumimoto H; Hiraki A; Suzuki T; Yatabe Y; Komori K; Kanemitsu Y; Hirai T; Kato T; Ueda M; Ishizaki K; Tajima K Carcinogenesis; 2008 Feb; 29(2):316-20. PubMed ID: 18174257 [TBL] [Abstract][Full Text] [Related]
17. Differing phenotypes between intraepithelial and stromal lymphocytes in early-stage tongue cancer. Katou F; Ohtani H; Watanabe Y; Nakayama T; Yoshie O; Hashimoto K Cancer Res; 2007 Dec; 67(23):11195-201. PubMed ID: 18056444 [TBL] [Abstract][Full Text] [Related]
18. Up-regulation of NKG2D ligands by AML cells to increase sensitivity to NK cells: the tumour might strike back. Comment on "differentiation-promoting drugs up-regulate NKG2D ligand expression and enhance the susceptibility of acute myeloid leukemia cells to natural killer cell-mediated lysis" by Rohner et al. [Leuk Res 2007;31:1393-402]. Zimmer J; Michel T; Andrès E; Hentges F Leuk Res; 2008 Apr; 32(4):676-7. PubMed ID: 17920678 [No Abstract] [Full Text] [Related]
19. DNA damage and tumor surveillance: one trigger for two pathways. Höglund P Sci STKE; 2006 Jan; 2006(317):pe2. PubMed ID: 16403940 [TBL] [Abstract][Full Text] [Related]
20. Chimeric NKG2D modified T cells inhibit systemic T-cell lymphoma growth in a manner involving multiple cytokines and cytotoxic pathways. Zhang T; Barber A; Sentman CL Cancer Res; 2007 Nov; 67(22):11029-36. PubMed ID: 18006849 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]